A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

In a new study on mice, an experimental antibody treatment reduced the lingering after-effects of head injuries.

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more ...

A study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day ...

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...

Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with depression and suicidal thoughts- especially when anti-depressants and talk ...

A treatment tested by researchers in Boston found it improves motor function, coordination and spatial memory in mice. But it ...

The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat depression. Parkside Psychiatric Hospital has a Spravato outpatient ...

Compass Pathways gains Stifel's Buy rating as its COMP360 psilocybin treatment advances in Phase 3 trials. Key depression ...

A nasal spray being developed to target brain inflammation can also prove effective in treating traumatic brain injury (TBI) ...

A study conducted by researchers at Mass General Brigham analyzed the effects of the nasal anti-CD3 in a mouse model of TBI. The study suggests that the spray could reduce damage to the central ...